PD-Rx Pharmaceuticals recalls

PD-Rx Pharmaceuticals has 25 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 1 Jan 2025. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls25since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Jan 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 23 92%Class III 2 8%

Why pd-rx pharmaceuticals is recalled

By year

All pd-rx pharmaceuticals recalls, newest first

25 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDULoxetine DR USP, 30 mg recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsNitrosamine ImpurityFL, MS, WI
DrugCLASS IISimvastatin USP 40 mg recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IISimvastatin USP 20 mg recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IISimvastatin USP, 10 mg recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMontelukast Sodium USP, 10 mg-bottles recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIGlimepiride USP, 4 mg-bottles recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IILosartan Potassium Tablets, USP 25 mg recalled by PD-Rx PharmaceuticalsLosartan PotassiumPD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILosartan Potassium Tablets, USP 100 mg recalled by PD-Rx PharmaceuticalsLosartan PotassiumPD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILosartan Potassium Tablets, USP 50 mg recalled by PD-Rx PharmaceuticalsLosartan PotassiumPD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILosartan Potassium USP, 50 mg recalled by PD-Rx PharmaceuticalsLosartan PotassiumPD-Rx PharmaceuticalsNitrosamine Impurity14 states
DrugCLASS IImetformin HCL ER 500 mg, a) recalled by PD-Rx PharmaceuticalsMetformin Hydrochloride Extended ReleasePD-Rx PharmaceuticalsNitrosamine Impurity16 states
DrugCLASS IImetformin HCL ER 750 mg recalled by PD-Rx PharmaceuticalsMetformin Hydrochloride Extended ReleasePD-Rx PharmaceuticalsNitrosamine Impurity16 states
DrugCLASS IINature-Throid 1 GR (65 mg), Each Tablet Contains recalledPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsAZ, OK
DrugCLASS IImetFORMIN HCL ER 500 mg, a) recalled by PD-Rx PharmaceuticalsMetformin Hydrochloride Extended ReleasePD-Rx PharmaceuticalsNitrosamine ImpurityOK
DrugCLASS IImetFORMIN HCL ER USP 500 mg, a) recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsNitrosamine ImpurityOK
DrugCLASS IIDoxycycline Hyclate tablets USP, 100 mg recalledDoxycyclinePD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIranitidine hydrochloride, USP a) bottles recalledPD-Rx PharmaceuticalsNitrosamine Impurity12 states
DrugCLASS IIDoxycycline Hyclate USP Tablets, 100 mg recalledDoxycyclinePD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIncorporated Ibuprofen a) recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIIPhentermine Capsules, 15 mg, a) bottle recalled by PD-Rx PharmaceuticalsPhentermine HydrochloridePD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIFamotidine USP 20 mg, Rx, PKG recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIPhentermine Hydrochloride Capsules, USP, 15 mg recalledPhentermine HydrochloridePD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIAzithromycin 500 mg tablets, Rx Only, packaged in a) 1 count, b) recalledPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAzithromycin Tablets, USP, 250 mg recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIClonidine Hydrochloride Tablets, USP, 0.1 mg recalledPD-Rx PharmaceuticalsManufacturing (CGMP) DeviationsAL

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.